| The cost of implantable defibrillators: perceptions and reality. | |
| | |
MedLine Citation:
|
PMID: 16887857 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
AIMS: Recent guidelines have recommended more wide-ranging indications for the use of implantable cardioverter defibrillator (ICD) therapy, yet even more restrained previous guidelines have not been implemented for a variety of reasons. METHODS AND RESULTS: This brief review critically examines the reasons most frequently put forward to explain this failure. Contrary to the frequently repeated speculation that the risk stratification for sudden death and hence prophylactic placement of ICDs is reasonably accurate, there is little cost difference between pharmacotherapy and ICD treatment over the long term. ICD therapy does not utilize an undue proportion of the healthcare budget, and the healthcare systems in Europe can afford this therapy. CONCLUSION: Financial reasons are neither accurate nor adequate explanations for the failure of the European medical community to implement European guidelines for the implantation of ICDs for primary and secondary prevention of sudden cardiac death. |
| | |
Authors:
|
John Camm; Helmut Klein; Seah Nisam |
Related Documents
:
|
20456647 - Recurrent implantable cardioverter-defibrillator replacement is associated with an incr... 16000917 - Implantable cardioverter defibrillator therapy. 22492677 - Functional biomaterials for cartilage regeneration. 1279587 - The measurement of the paced depolarization integral using the braided endocardial lead. 18401287 - The impact of cochlear implants from the perspective of significant others of adult coc... 17209827 - Dynamic recording of irrigating fluid distribution in root canals using thermal image a... |
Publication Detail:
|
Type: Journal Article; Review Date: 2006-08-03 |
Journal Detail:
|
Title: European heart journal Volume: 28 ISSN: 0195-668X ISO Abbreviation: Eur. Heart J. Publication Date: 2007 Feb |
Date Detail:
|
Created Date: 2007-02-16 Completed Date: 2007-11-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8006263 Medline TA: Eur Heart J Country: England |
Other Details:
|
Languages: eng Pagination: 392-7 Citation Subset: IM |
Affiliation:
|
St George's University of London, Cranmer Terrace, London SW17 0RE, UK. jcamm@sgul.ac.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Cardiovascular Agents
/
economics Cost-Benefit Analysis Death, Sudden, Cardiac / prevention & control* Defibrillators, Implantable / economics* Drug Costs Health Expenditures Humans Quality-Adjusted Life Years |
| Chemical | |
Reg. No./Substance:
|
0/Cardiovascular Agents |
| Comments/Corrections | |
Comment In:
|
Eur Heart J. 2007 Feb;28(4):386-7
[PMID:
17289746
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Benefits of achieving the NCEP optional LDL-C goal among elderly patients with ACS.
Next Document: Pride, prejudice, and paediatrics (women paediatricians in England before 1950).